Page 8 - Sirnaomics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sirnaomics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sirnaomics Inc Today - Breaking & Trending Today

Sirnaomics Enters Partnership with Walvax Biotechnology to Co-Develop Its Antiviral RNAi Therapeutic Product Candidate STP702

Published: Apr 29, 2021

GAITHERSBURG, Md. and SUZHOU BIOBAY, China, April 29, 2021 /PRNewswire/ Sirnaomics (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer, fibrotic diseases and viral infections, announced today that the company has entered into a partnership agreement with Walvax Biotechnology (Walvax) for the co-development of its anti-influenza siRNA therapeutic product candidate STP702. Sirnaomics will out-license to Walvax the exclusive development and commercialization rights for territories including mainland China, Taiwan, Hong Kong and Macao. Based on the agreement, the company will receive an initial payment of ~US$6.4 million for this asset, with additional milestone payments and royalty sharing based on product sales. ....

United States , Hong Kong , Macau General , Allan Shaw , Mark Corbae , Stephanie Carrington , David Evans , Walvax Bio , Patrick Lu , Prnewswire Sirnaomics Suzhou Co , Walvax Biotechnology Co Ltd , Sirnaomics Inc , Walvax Biotechnology , Chief Financial Officer , Global Vision , Patient Centered , Scientific Officer , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , மக்காவு ஜநரல் , ஆலன் ஷா , மாற்றாந்தாய் கேரிங்டன் , டேவிட் எவன்ஸ் , பேட்ரிக் லு , தலைமை நிதி அதிகாரி , உலகளாவிய பார்வை ,

Sirnaomics Enters Partnership with Walvax Biotechnology to Co-Develop Its Antiviral RNAi Therapeutic Product Candidate STP702

Share this article
Share this article
GAITHERSBURG, Md. and SUZHOU BIOBAY, China, April 29, 2021 /PRNewswire/ Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer, fibrotic diseases and viral infections, announced today that the company has entered into a partnership agreement with Walvax Biotechnology (Walvax) for the co-development of its anti-influenza siRNA therapeutic product candidate STP702. Sirnaomics will out-license to Walvax the exclusive development and commercialization rights for territories including mainland China, Taiwan, Hong Kong and Macao. Based on the agreement, the company will receive an initial payment of ~US$6.4 million for this asset, with additional milestone payments and royalty sharing based on product sales. ....

United States , Hong Kong , Macau General , Allan Shaw , Mark Corbae , Stephanie Carrington , David Evans , Walvax Bio , Patrick Lu , Prnewswire Sirnaomics Biopharmaceuticals Suzhou Co , Walvax Biotechnology Co Ltd , Sirnaomics Inc , Walvax Biotechnology , Chief Financial Officer , Global Vision , Patient Centered , Scientific Officer , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , மக்காவு ஜநரல் , ஆலன் ஷா , மாற்றாந்தாய் கேரிங்டன் , டேவிட் எவன்ஸ் , பேட்ரிக் லு , தலைமை நிதி அதிகாரி , உலகளாவிய பார்வை ,

Sirnaomics, Walvax to develop antiviral RNAi therapeutic product candidate

Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary ....

Sirnaomics Inc , Sirnaomics Biopharmaceuticals , Walvax Biotechnology ,

Sirnaomics Enters Partnership with Walvax Biotechnology to Co-Develop Its Antiviral RNAi Therapeutic Product Candidate STP702

Sirnaomics Enters Partnership with Walvax Biotechnology to Co-Develop Its Antiviral RNAi Therapeutic Product Candidate STP702
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , Macau General , Allan Shaw , Mark Corbae , Stephanie Carrington , David Evans , Walvax Bio , Patrick Lu , Prnewswire Sirnaomics Biopharmaceuticals Suzhou Co , Walvax Biotechnology Co Ltd , Sirnaomics Inc , Walvax Biotechnology , Chief Financial Officer , Global Vision , Patient Centered , Scientific Officer , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , ஆலன் ஷா , மாற்றாந்தாய் கேரிங்டன் , டேவிட் எவன்ஸ் , பேட்ரிக் லு , தலைமை நிதி அதிகாரி , உலகளாவிய பார்வை , நோயாளி மையமாக ,